|
Hello,
The FDA Intergovernmental Affairs team would like to bring to your attention that today, the U.S. Food and Drug Administration has posted background material regarding the next Vaccine and Related Biological Products Advisory Committee (VRBPAC) meeting to discuss EUA request by Novavax for a vaccine to prevent COVID-19 in individuals 18 years of age and older.
Event materials are now available online for our next VRBPAC meeting, which is scheduled for Tuesday, June 7, 2022.
- The draft roster document and other materials are posted here.
- The agenda can be found on our website here.
-
FDA’s Briefing Document – can be found on our website here.
I hope this information is helpful. For information on COVID-19 Vaccines, please visit FDA’s webpage here. Please feel free to contact me or FDA’s IGA staff at IGA@fda.hhs.gov if you have any questions. Thank you.
Regards,
Akeisha Brown
Management Analyst
Intergovernmental Affairs (IGA)
Office of the Commissioner/OPLIA
U.S. Food and Drug Administration
Tel: 240.678.4778
Akeisha.Brown@fda.hhs.gov
|
|
|
|
